Foxo3a: An integrator of immune dysfunction during HIV infection

Cytokine and Growth Factor Reviews

Volumn 23, Issue 4-5, 2012, Pages 215-221

  Van Grevenynghe, Julien ^a   Cubas, Rafael A ^a   DaFonseca, Sandrina ^a,b,c   Metcalf, Talibah ^a   Tremblay, Cecile L ^b,c   Trautmann, Lydie ^a   Sekaly, Rafick Pierre ^a   Schatzle, John ^a   Haddad, Elias K ^a  

^a Vaccine and Gene Therapy Institute of Florida (VGTI Florida)   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; EC; Foxo3a; HIV; Memory; Microenvironment

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 2; INTERLEUKIN 21; TRANSCRIPTION FACTOR FKHRL1; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DEATH; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; GENE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFECTION CONTROL; INNATE IMMUNITY; MACROPHAGE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIREMIA; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; HEMATOPOIESIS; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 84864920849     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.05.008     Document Type: Article

References (93)

1. Biancotto A., Grivel J.C., Iglehart S.J., Vanpouille C., Lisco A., Sieg S.F., et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007, 109:4272-4279.
2. Breen E.C. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacology & Therapeutics 2002, 95:295-304.
3. Decrion A.Z., Dichamp I., Varin A., Herbein G. HIV and inflammation. Current HIV Research 2005, 3:243-259.
4. Herbeuval J.P., Nilsson J., Boasso A., Hardy A.W., Kruhlak M.J., Anderson S.A., et al. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7000-7005.
5. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006, 12:1365-1371.
6. Schacker T.W., Nguyen P.L., Beilman G.J., Wolinsky S., Larson M., Reilly C., et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. Journal of Clinical Investigation 2002, 110:1133-1139.
7. Estes J.D., Wietgrefe S., Schacker T., Southern P., Beilman G., Reilly C., et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. Journal of Infectious Diseases 2007, 195:551-561.
8. Bekker V., Scherpbier H., Pajkrt D., Jurriaans S., Zaaijer H., Kuijpers T.W. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 2006, 118:e315-e322.
9. Iannello A., Boulassel M.R., Samarani S., Debbeche O., Tremblay C., Toma E., et al. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. Journal of Immunology 2010, 184:114-126.
10. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grutzmeier S., Atlas A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006, 108:1580-1587.
11. Van grevenynghe J., Cubas R.A., Noto A., Dafonseca S., He Z., Peretz Y., et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. The Journal of Clinical Investigation 2011, 121:3877-3888.
12. van Grevenynghe J., Procopio F.A., He Z., Chomont N., Riou C., Zhang Y., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nature Medicine 2008, 14:266-274.
13. Probst H.C., McCoy K., Okazaki T., Honjo T., van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nature Immunology 2005, 6:280-286.
14. Elrefaei M., Burke C.M., Baker C.A., Jones N.G., Bousheri S., Bangsberg D.R., et al. HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4. AIDS Research and Human Retroviruses 2010, 26:329-337.
15. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. Journal of Experimental Medicine 2006, 203:2281-2292.
16. Porichis F., Kwon D.S., Zupkosky J., Tighe D.P., McMullen A., Brockman M.A., et al. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. Blood 2011, 118:965-974.
17. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature Medicine 2006, 12:1198-1202.
18. Migliaccio M., Alves P.M., Romero P., Rufer N. Distinct mechanisms control human naive and antigen-experienced CD8+ T lymphocyte proliferation. Journal of Immunology 2006, 176:2173-2182.
19. Riou C., Yassine-Diab B., Van grevenynghe J., Somogyi R., Greller L.D., Gagnon D., et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. Journal of Experimental Medicine 2007, 204:79-91.
20. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunology 2000, 1:426-432.
21. Landires I., Bugault F., Lambotte O., de Truchis P., Slama L., Danckaert A., et al. HIV infection perturbs IL-7 signaling at the step of STAT5 nuclear relocalization. AIDS 2011.
22. Allard D., Figg N., Bennett M.R., Littlewood T.D. Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3. Journal of Biological Chemistry 2008, 283:19739-19747.
23. Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E. Protein kinase SGK mediates survival signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a). Molecular and Cellular Biology 2001, 21:952-965.
24. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
25. Burgering B.M., Medema R.H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. Journal of Leukocyte Biology 2003, 73:689-701.
26. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
27. Birkenkamp K.U., Coffer P.J. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochemical Society Transactions 2003, 31:292-297.
28. Kops G.J., Medema R.H., Glassford J., Essers M.A., Dijkers P.F., Coffer P.J., et al. Control of cell cycle exit and entry by protein kinase B-regulated Forkhead transcription factors. Molecular and Cellular Biology 2002, 22:2025-2036.
29. Choi J., Oh S., Lee D., Oh H.J., Park J.Y., Lee S.B., et al. Mst1-FoxO signaling protects Naive T lymphocytes from cellular oxidative stress in mice. PLoS One 2009, 4:e8011.
30. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
31. Nakamura T., Sakamoto K. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Molecular and Cellular Endocrinology 2008, 281:47-55.
32. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
33. Greer E.L., Oskoui P.R., Banko M.R., Maniar J.M., Gygi M.P., Gygi S.P., et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. Journal of Biological Chemistry 2007, 282:30107-30119.
34. Birkenkamp K.U., Coffer P.J. FOXO transcription factors as regulators of immune homeostasis: molecules to die for?. Journal of Immunology 2003, 171:1623-1629.
35. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
36. Poonia B., Salvato M.S., Yagita H., Maeda T., Okumura K., Pauza C.D. Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus. Blood 2009, 114:1196-1204.
37. Gougeon M.L. Apoptosis as an HIV strategy to escape immune attack. Nature Reviews Immunology 2003, 3:392-404.
38. Li C.J., Friedman D.J., Wang C., Metelev V., Pardee A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268:429-431.
39. Miyamoto K., Miyamoto T., Kato R., Yoshimura A., Motoyama N., Suda T. FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging. Blood 2008, 112:4485-4493.
40. Miyamoto K., Araki K.Y., Naka K., Arai F., Takubo K., Yamazaki S., et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1:101-112.
41. Moller C., Alfredsson J., Engstrom M., Wootz H., Xiang Z., Lennartsson J., et al. Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood 2005, 106:1330-1336.
42. Tothova Z., Gilliland D.G. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 2007, 1:140-152.
43. Mandal M., Crusio K.M., Meng F., Liu S., Kinsella M., Clark M.R., et al. Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:20840-20845.
44. Bakker W.J., Blazquez-Domingo M., Kolbus A., Besooyen J., Steinlein P., Beug H., et al. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. Journal of Cell Biology 2004, 164:175-184.
45. Bakker W.J., van Dijk T.B., Parren-van Amelsvoort M., Kolbus A., Yamamoto K., Steinlein P., et al. Differential regulation of Foxo3a target genes in erythropoiesis. Molecular and Cellular Biology 2007, 27:3839-3854.
46. Mahmud D.L.M.G.A., Deb D.K., Platanias L.C., Uddin S., Wickrema A. Phosphorylation of Forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 2002, 21:1556-1562.
47. Barclay J.L., Anderson S.T., Waters M.J., Curlewis J.D. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Molecular Endocrinology 2007, 21:2503-2515.
48. Duy C., Yu J.J., Nahar R., Swaminathan S., Kweon S.M., Polo J.M., et al. BCL6 is critical for the development of a diverse primary B cell repertoire. Journal of Experimental Medicine 2010, 207:1209-1221.
49. Herzog S., Hug E., Meixlsperger S., Paik J.H., DePinho R.A., Reth M., et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nature Immunology 2008, 9:623-631.
50. Harada Y., Harada Y., Elly C., Ying G., Paik J.H., DePinho R.A., et al. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. Journal of Experimental Medicine 2010, 207:1381-1391.
51. Merkenschlager M., von Boehmer H. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. Journal of Experimental Medicine 2010, 207:1347-1350.
52. Dejean A.S., Beisner D.R., Ch'en I.L., Kerdiles Y.M., Babour A., Arden K.C., et al. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nature Immunology 2009, 10:504-513.
53. Huntington N.D., Puthalakath H., Gunn P., Naik E., Michalak E.M., Smyth M.J., et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nature Immunology 2007, 8:856-863.
54. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., et al. IkappaB kinase promotes tumorigenesis through inhibition of Forkhead FOXO3a. Cell 2004, 117:225-237.
55. Kornblau S.M., Singh N., Qiu Y., Chen W., Zhang N., Coombes K.R. Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia. Clinical Cancer Research 2010, 16:1865-1874.
56. Yang J.Y., Hung M.C. A new fork for clinical application: targeting Forkhead transcription factors in cancer. Clinical Cancer Research 2009, 15:752-757.
57. Kikuchi S., Nagai T., Kunitama M., Kirito K., Ozawa K., Komatsu N. Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Science 2007, 98:1949-1958.
58. Kong W., He L., Coppola M., Guo J., Esposito N.N., Coppola D., et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. Journal of Biological Chemistry 2010, 285:17869-17879.
59. Sakoe Y., Sakoe K., Kirito K., Ozawa K., Komatsu N. FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia. Blood 2010, 115:3787-3795.
60. Sunters A., Madureira P.A., Pomeranz K.M., Aubert M., Brosens J.J., Cook S.J., et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Research 2006, 66:212-220.
61. Wu W., Zou M., Brickley D.R., Pew T., Conzen S.D. Glucocorticoid receptor activation signals through Forkhead transcription factor 3a in breast cancer cells. Molecular Endocrinology 2006, 20:2304-2314.
62. Essafi M., Baudot A.D., Mouska X., Cassuto J.P., Ticchioni M., Deckert M. Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells. Molecular Cancer Therapeutics 2011, 10:37-46.
63. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nature Immunology 2007, 8:74-83.
64. Jonsson H., Allen P., Peng S.L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nature Medicine 2005, 11:666-671.
65. Lin L., Hron J.D., Peng S.L. Regulation of NF-kappaB, Th activation, and autoinflammation by the Forkhead transcription factor Foxo3a. Immunity 2004, 21:203-213.
66. Li D., Qu Y., Mao M., Zhang X., Li J., Ferriero D., et al. Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. Journal of Cerebral Blood Flow and Metabolism 2009, 29:1903-1913.
67. Maiese K., Chong Z.Z., Shang Y.C. " Sly as a FOXO" : new paths with Forkhead signaling in the brain. Current Neurovascular Research 2007, 4:295-302.
68. Qin W., Zhao W., Ho L., Wang J., Walsh K., Gandy S., et al. Regulation of Forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Annals of the New York Academy of Sciences 2008, 1147:335-347.
69. Relling D.P., Esberg L.B., Fang C.X., Johnson W.T., Murphy E.J., Carlson E.C., et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. Journal of Hypertension 2006, 24:549-561.
70. Su B., Liu H., Wang X., Chen S.G., Siedlak S.L., Kondo E., et al. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Molecular Neurodegeneration 2009, 4:32.
71. Cicala C., Arthos J., Rubbert A., Selig S., Wildt K., Cohen O.J., et al. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1178-1183.
72. Jacotot E., Ravagnan L., Loeffler M., Ferri K.F., Vieira H.L., Zamzami N., et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Journal of Experimental Medicine 2000, 191:33-46.
73. Selliah N., Finkel T.H. Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death and Differentiation 2001, 8:127-136.
74. Dabrowska A., Kim N., Aldovini A. Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. Journal of Immunology 2008, 181:8460-8477.
75. Kim N., Kukkonen S., Gupta S., Aldovini A. Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells. PLoS Pathogens 2010, 6:e1001103.
76. Kino T., De Martino M.U., Charmandari E., Ichijo T., Outas T., Chrousos G.P. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of Forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes 2005, 54:23-31.
77. Fichtenbaum C.J. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Current Infectious Disease Reports 2009, 11:84-92.
78. Wilk A., Urbanska K., Yang S., Wang J.Y., Amini S., Del Valle L., et al. Insulin-like growth factor-I-Forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-alpha-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. Journal of Neuroscience Research 2011, 89:183-198.
79. Cui M., Huang Y., Zhao Y., Zheng J. Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. Journal of Immunology 2008, 180:898-906.
80. Huang Y., Erdmann N., Peng H., Herek S., Davis J.S., Luo X., et al. TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation. Journal of Immunology 2006, 177:2304-2313.
81. van Grevenynghe J., Halwani R., Chomont N., Ancuta P., Peretz Y., Tanel A., et al. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection. Seminars in Immunology 2008, 20:196-203.
82. Younes S.A., Yassine-Diab B., Dumont A.R., Boulassel M.R., Grossman Z., Routy J.P., et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. Journal of Experimental Medicine 2003, 198:1909-1922.
83. Cerutti A. HIV infection: TRAILing the killers. Blood 2009, 114:3723-3724.
84. Herbeuval J.P., Boasso A., Grivel J.C., Hardy A.W., Anderson S.A., Dolan M.J., et al. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 2005, 105:2458-2464.
85. Kaplan D., Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. Journal of Virology 1998, 72:6279-6282.
86. Poonia B., Pauza C.D., Salvato M.S. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology 2009, 6:91.
87. Stary G., Klein I., Kohlhofer S., Koszik F., Scherzer T., Mullauer L., et al. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood 2009, 114:3854-3863.
88. Deeks S.G., Walker B.D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007, 27:406-416.
89. Bello G., Velasco-de-Castro C.A., Bongertz V., Rodrigues C.A., Giacoia-Gripp C.B., Pilotto J.H., et al. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. Journal of Medical Virology 2009, 81:1681-1690.
90. Fonseca S.G., Procopio F.A., Goulet J.P., Yassine-Diab B., Ancuta P., Sekaly R.P. Unique features of memory T cells in HIV elite controllers: a systems biology perspective. Current Opinion in HIV and AIDS 2011, 6:188-196.
91. Nakayama K., Nakamura H., Koga M., Koibuchi T., Fujii T., Miura T., et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Research and Human Retroviruses 2011, [Epub ahead of print].
92. Sachdeva M., Fischl M.A., Pahwa R., Sachdeva N., Pahwa S. Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 2010, 54:447-454.
93. Yamamoto T., Price D.A., Casazza J.P., Ferrari G., Nason M., Chattopadhyay P.K., et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood 2011, 117:4805-4815.